Stock Comparison
ABT vs PEN
Abbott Laboratories and Penumbra Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$12.82B
P/E (TTM)
35.7
80.2
Forward P/E
20.0
68.2
Price/Sales
4.1
8.5
Price/Book
3.7
8.4
EV/EBITDA
18.6
55.7
Dividend Yield
1.66%
—
Profitability
Net Margin
13.91%
11.76%
Operating Margin
18.17%
12.87%
Return on Equity
10.60%
11.40%
Return on Assets
5.33%
6.42%
Growth (YoY)
Revenue Growth
13.00%
14.90%
Earnings Growth
-47.50%
-23.50%
Price & Risk
Beta
0.6
0.7
52-Week High
$134.48
$359.40
52-Week Low
$82.56
$225.54
Analyst Target
$118.42
$361.83
Compare ABT and PEN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.